Programa sobre Trastorno Bipolar del 26 ECNP Barcelona 2013 Más información en www.puedoser.es

1. C.03: Prioritising the patient in the management of
major depressive disorder
Educational financial support provided by AstraZeneca
Saturday 15:45 - 17:30
Room: Room H
Chair
Koen Demyttenaere, Belgium
Presentations
C.03.01: How confidently can we predict response in patients with MDD?
Philip Gorwood, France
C.03.02: From hopelessness to hope: a patient-centred approach
Hamish McAllister-Williams, United Kingdom
C.03.03: New pharmacotherapeutic opportunities for the treatment of
depression
Brian Leonard, Ireland
Session Type
Satellite symposium
C.08: Bipolar disorder: the evolving story
Educational financial support provided by AstraZeneca
Sunday 16:45 - 18:30
Room: Room J
Chair
Roger McIntyre, Canada
Presentations
C.08.01: Improving patient outcomes in bipolar disorder
Eduard Vieta, Spain
C.08.02: A disease for life? Beyond acute episodes in bipolar disorder
Guy Goodwin, United Kingdom
Session Type
Satellite symposium
C.13: The multidimensional perspective of Bipolar I
disorder
Monday 16:45 - 18:30
Room: Room M2
Chair
Andrea Fagiolini, Italy
Presentations

2. C.13.01: The manic depressive spectrum, the DSM5 perspective
Andrea Fagiolini, Italy
C.13.02: Bipolar mixed states, recognition and course
Allan H. Young, United Kingdom
C.13.03: Treatment of mixed states
Michael Berk, Australia
Session Type
Satellite symposium
S.25: Genetic implications in bipolar disorder
Wednesday 09:00 - 10:40
Room: Auditorium
Chair
István Bitter, Hungary
Presentations
09:00-09:25
S.25.01: Pharmacogenetics of antidepressant, antiepileptic and neuroleptic
drug treatment
Leif Bertilsson, Sweden
09:25-09:50
S.25.02: Molecular genetic aspects to serotonergic drugs in bipolar disorder
Xenia Gonda, Hungary
09:50-10:15
S.25.03: Pharmacogenetics of efficacy and treatment side effects in bipolar
disorder
Alessandro Serretti, Italy
10:15-10:40
S.25.04: Genetics of suicidal behaviour in bipolar disorder: an update
Antoni Benabarre, Spain
Session Type
Symposium
Track
Clinical Treatment track
S.25: Genetic implications in bipolar disorder
Wednesday 09:00 - 10:40
Room: Auditorium
Chair
István Bitter, Hungary
Presentations
09:00-09:25
S.25.01: Pharmacogenetics of antidepressant, antiepileptic and neuroleptic
drug treatment
Leif Bertilsson, Sweden
09:25-09:50
S.25.02: Molecular genetic aspects to serotonergic drugs in bipolar disorder

3. Xenia Gonda, Hungary
09:50-10:15
S.25.03: Pharmacogenetics of efficacy and treatment side effects in bipolar
disorder
Alessandro Serretti, Italy
10:15-10:40
S.25.04: Genetics of suicidal behaviour in bipolar disorder: an update
Antoni Benabarre, Spain